Insider Ownership Filing for CytoMed Therapeutics Ltd

This filing reports the initial ownership of Yvonne Goh, Chief Financial Officer of CytoMed Therapeutics Ltd (GDTC), as of March 18, 2026. Ms. Goh directly owns 25,781 ordinary shares. The filing is made on Form 3, an initial statement of beneficial ownership of securities.